Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-024647
Filing Date
2019-04-29
Accepted
2019-04-29 17:25:24
Documents
5
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2478_3defa14a.htm DEFA14A 32343
2 GRAPHIC g24783bgi001.gif GRAPHIC 35802
3 GRAPHIC g24783bgi002.gif GRAPHIC 58881
4 GRAPHIC g24783bgi003.gif GRAPHIC 14613
5 GRAPHIC g24783bgi004.gif GRAPHIC 1309
  Complete submission text file 0001104659-19-024647.txt   186221
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 19777238
SIC: 2834 Pharmaceutical Preparations